Unveiling the Impact of Tumor-Infiltrating Lymphocytes (TILs) on Solid Tumors & the TCR Landscape
Time: 5:40 pm
day: Conference Day One
Details:
• Exploring the potential of TILs as a groundbreaking avenue for cancer treatment by leveraging the body’s immune system to combat solid tumors
• Understanding the pivotal role of TILs as prognostic indicators and their ability to infiltrate and target solid tumor microenvironments for therapeutic interventions
• Delving into the diverse and specialized T cell receptor (TCR) repertoires present within TILs and their critical role in orchestrating effective immune responses against various types of solid tumors
